OSPAMOX

This brand name is authorized in Austria, Croatia, Estonia, Hong Kong SAR China, Lithuania, New Zealand, Nigeria, Poland, Romania, Singapore.

Active ingredients

The drug OSPAMOX contains one active pharmaceutical ingredient (API):

1
UNII 804826J2HU - AMOXICILLIN
 

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

 
Read more about Amoxicillin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 OSPAMOX Powder for oral suspension / Paediatric drops MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01CA04 Amoxicillin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1181999, 1182002, 1306774, 1306785, 1306796, 1306808, 1306819, 1306820, 1306831, 1306842, 1306853, 1306864, 1306875, 1306886, 1306897, 1306909, 1306910, 1306921, 1306932, 1306943, 1306954, 1306965
HK Department of Health Drug Office 32357, 33168
HR Agencija za lijekove i medicinske proizvode HR-H-326396791
LT Valstybinė vaistų kontrolės tarnyba 1005024, 1005025, 1005581, 1005582, 1026247, 1026248, 1026268, 1026272, 1026273, 1026284, 1027094, 1032143, 1032144, 1032145, 1032146, 1032147, 1032148, 1032159, 1032160, 1032161, 1032162, 1032163, 1032164, 1032165, 1032166, 1032167, 1032168, 1032169, 1032170, 1032171, 1032172, 1052833, 1052835, 1052836, 1052837, 1052838, 1052839, 1052840, 1052841, 1052842, 1052844, 1052845, 1052846, 1052847, 1052848, 1052849, 1052850, 1053222, 1053223, 1053224, 1060289, 1093333
NG Registered Drug Product Database B4-3580
Switch country to Nigeria in order to find specific presentations of OSPAMOX
NZ Medicines and Medical Devices Safety Authority 8381, 8382, 8723, 8724, 8763, 9763
PL Rejestru Produktów Leczniczych 100049954, 100049960, 100049977, 100157916, 100226468, 100227440, 100229030, 100229047, 100468886
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W00388002, W00388003, W41578001, W41578002, W41580002, W41580003, W41600001, W41600002
SG Health Sciences Authority 02350P, 03690P, 03691P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.